OJOG  Vol.4 No.14 , October 2014
Expression of Toll-Like Receptor-2 and -4 in Amniochorion Membranes of Preterm Delivery in the Presence of Histologic Chorioamnionitis
Abstract: Expression of Toll-like receptors at the maternal-fetal interface during normal and complicated pregnancies has aroused interest in the last few years. However, despite the importance of TLR-2 and TLR-4, which recognizes most microorganisms presenting in the amniotic cavity infections associated with prematurity, comparison of the expressions of these receptors is rare in the literature. Thus, the purpose of this study was to compare the gene expression between TLR-2 and TLR-4 in amniochorion membranes of pregnant women with preterm delivery in the presence of histologic chorioamnionitis (HCA). Amniochorion membranes were collected from 40 pregnant women with preterm delivery; 20 presented HCA and 20 did not. Fragments of the membranes were submitted to total RNA extraction, followed by cDNA production by reverse transcription. Real time quantitative PCR was used to quantify the gene expression of the TLRs. mRNA concentrations between TLR-2 and TLR-4 were compared using the nonparametric Mann-Whitney test. TLR-2 expression was higher than TLR-4 expression in the presence of HCA. No difference was observed between TLR-2 and TLR-4 expression in membranes in the absence of inflammatory infiltrate. In conclusion, amniochorion membranes express TLR-2 and TLR-4 and higher TLR-2 expression in the presence of histologic chorioamnionitis suggests that microorganisms recognizable by TLR-2 play an important role in the physiopathology of preterm labor.
Cite this paper: Moço, N. , Martin, L. , Polettini, J. , Pereira, A. , Peraçoli, J. and Silva, M. (2014) Expression of Toll-Like Receptor-2 and -4 in Amniochorion Membranes of Preterm Delivery in the Presence of Histologic Chorioamnionitis. Open Journal of Obstetrics and Gynecology, 4, 857-863. doi: 10.4236/ojog.2014.414120.

[1]   King, A.E., Paltoo, A., Kelly, R.W., et al. (2007) Expression of Natural Antimicrobials by Human Placenta and Fetal Membranes. Placenta, 28, 161-169.

[2]   Polettini, J., Takitane, J., Peracoli, J.C. and Silva, M.G. (2011) Expression of β Defensins 1,3 and 4 in Chorioamniotic Membranes of Preterm Pregnancies Complicated by Chorioamnionitis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 157, 150-155.

[3]   Polettini, J., Pera?oli, J.C., Candeias, J.M.G., Araújo Júnior, J.P. and Silva, M.G. (2009) Inflammatory Cytokine mRNA Detection by Real Time PCR in Chorioamniotic Membranes from Pregnant Women with Preterm Premature Rupture of Membranes. European Journal of Obstetrics & Gynecology and Reproductive Biology, 144, 27-33.

[4]   Zaga-Clavellina, V., Garcia-Lopez, G., Flores-Herrera, H., Espejel-Nunez, A., Flores-Pliego, A., Soriano-Becerrio, D., Maida-Claros, R., Merchant-Larios, H. and Vadillo-Ortega, F. (2007) In Vitro Secretion Profiles of Interlukin (IL)-1 Beta, IL-6, Il-8, IL-10 and TNF-Alpha after Selective Infection with Escherichia coli in Human Fetal Membranes. Reproductive Biology and Endocrinology, 13, 5-46.

[5]   Kim, Y.M., Romero, R., Chaiworapongsa, T., et al. (2004) Toll-Like Receptor-2 and -4 in the Chorioamniotic Membranes in Spontaneous Labor at Term and in Preterm Parturition That Are Associated with Chorioamnionitis. American Journal of Obstetrics Gynecology, 191, 1346-1355.

[6]   Akira, S., Takeda, K. and Kaisho, T. (2001) Toll-Like Receptors: Critical Proteins Linking Innate and Acquired Immunity. Nature Immunology, 2, 675-680.

[7]   Aderem, A. and Ulevitch, R.J. (2000) Toll-Like Receptors in the Induction of the Innate Immune Response. Nature, 406, 782-787.

[8]   Abbas, A.K. and Lichtman, A.H. (2005) Imunologia celular e molecular. 5th Edition, Elsevier, Rio de Janeiro.

[9]   Abreu, M., Fukata, M. and Arditi, M. (2005) TLR Signaling in the Gut in Health and Disease. The Journal of Immunology, 174, 4453-4460.

[10]   Fazeli, A., Bruce, C. and Anumba, D. (2005) Characterization of Toll-Like Receptors in the Female Reproductive Tract in Humans. Human Reproduction, 20, 1372-1378.

[11]   Beijar, E.C., Mallard, C. and Powell, T.L. (2006) Expression and Subcellular Localization of TLR-4 in Term and First Trimester Human Placenta. Placenta, 27, 322-326.

[12]   Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. and Kirschning, C. (1999) Peptidoglycan- and Lipoteichoic Acid-Induced Cell Activation Is Mediates by Toll-Like Receptor 2. Journal of Biological Chemistry, 274, 17406-17409.

[13]   Yoshimura, A., Lien, E., Ingalls, R., Tuomanen, E., Dziarski, R. and Golenbock, D. (1999) Cutting Edge: Recognition of Gram-Positive Bacterial Cell Wall Components by the Innate Immune System Occurs via Toll-Like Receptor 2. Journal of Immunology, 163, 1-5.

[14]   Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-Like Receptors. Annual Review of Immunology, 21, 335-376.

[15]   Underhill, D., Ozinsky, A., Hajjar, A., Stevens, A., Wilson, C.B., Bassetti, M. and Aderem, A. (1999) The Toll-Like Receptor 2 Is Recruited to Macrophage Phagosomes and Discriminates between Pathogens. Nature, 401, 811-815.

[16]   DiGiulio, D.B., Romero, R., Amogan, H.P., Kusanovic, J.P., Bik, E.M., Gotsch, F., et al. (2008) Microbial Prevalence, Diversity and Abundance in Amniotic Fluid during Preterm Labor: A Molecular and Culture-Based Investigation. PLoS ONE, 3, e3056.

[17]   Nguyen, D.P., Gerber, S., Hohlfeld, P., Sandrine, G. and Witkin, S.S. (2004) Mycoplasma Hominis in Mid-Trimester Amniotic Fluid: Relation to Pregnancy Outcome. Journal of Perinatal Medicine, 32, 323-326.

[18]   Perni, S.C., Vardhana, S., Korneeva, I., Tuttle, S.L., Paraskevas, L.R., Chasen, S.T., Kalish, R.B. and Witkin, S.S. (2004) Mycoplasma hominis and Ureaplasma urealyticum in Midtrimester Amniotic Fluid: Association with Amniotic Fluid Cytokine Levels and Pregnancy Outcome. American Journal of Obstetrics & Gynecology, 191, 1382-1386.

[19]   Yoon, B.H., Romero, R., Lim, J.H., Shim, S.S., Hong, J.S., Shim, J.Y. and Jun, J.K. (2003) The Clinical Significance of Detecting Ureaplasma urealyticum by the Polymerase Chain Reaction in the Amniotic Fluid of Patients with Preterm Labor. American Journal of Obstetrics & Gynecology, 189, 919-924.

[20]   Kim, M.J., Romero, R., Gervasi, M.T., Kim, J.S., Yoo, W., Lee, D.C., et al. (2009) Widespread Microbial Invasion of the Chorioamniotic Membranes Is a Consequence and Not a Cause of Intra-Amniotic Infection. Laboratory Investigation, 89, 924-936.

[21]   Jones, H.E., Harris, K.A., Azizia, M., Bank, L., Carpenter, B., Hartley, J.C., Klein, N. and Peebles, D. (2009) Differing Prevalence and Diversity of Bacterial Species in Fetal Membranes from Very Preterm and Term Labor. PLoS ONE, 4, e8205.

[22]   Donders, G.G., Van Calsteren, K., Bellen, G., Reybrouck, R., Van den Bosch, T., Riphagen, I. and Van Lierde, S. (2009) Predictive Value for Preterm Birth of Abnormal Vaginal Flora, Bacterial Vaginosis and Aerobic Vaginitis during the First Trimester of Pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 116, 1315-1324.

[23]   Marconi, C., de Andrade Ramos, B.R., Peracoli, J.C., Donders, G.G. and da Silva, M.G. (2011) Amniotic Fluid Interleukin-1 Beta and Interleukin-6, but Not Interleukin-8 Correlate with Microbial Invasion of the Amniotic Cavity in Preterm Labor. American Journal of Reproductive Immunology, 65, 549-556.

[24]   Kumazaki, K., Nakayama, M., Yanagihara, I., Suehara, N. and Wada, Y. (2004) Immunohistochemical Distribution of Toll-Like Receptor 4 in Term and Preterm Human Placentas from Normal and Complicated Pregnancy Including Chorioamnionitis. Human Pathology, 35, 47-54.

[25]   Yoon, B.H., Romero, R., Kim, C.J., Jun, J.K., Gomez, R., Choi, J.H. and Syu, H.C. (1995) Amniotic Fluid Interleukin-6: A Sensitive Test for Antenatal Diagnosis of Acute Inflammatory Lesions of Preterm Placenta and Prediction of Perinatal Morbidity. American Journal of Obstetrics & Gynecology, 172, 960-970.

[26]   Maier, T., Guell, M. and Serrano, L. (2009) Correlation of mRNA and Protein in Complex Biological Samples. FEBS Letters, 583, 3966-3973.

[27]   Livak, K.J. and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.

[28]   Kawai, T. and Akira, S. (2010) The Role of Pattern-Recognition Receptor in Innate Immunity: Update of Toll-Like Receptors. Nature Immunology, 11, 373-384.

[29]   Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., et al. (2002) Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins. Journal of Immunology, 169, 10-14.

[30]   Akira, S. (2003) Mammalian Toll-Like Receptors. Current Opinion in Immunology, 15, 5-11.

[31]   Forsum, U., Holst, E., Larsson, P.G., Vasquez, A., Jakobsson, T. and Mattsby-Baltzer, I. (2005) Bacterial Vaginosis—A Microbiological and Immunological Enigma. APMIS, 113, 81-90.

[32]   Yudin, M.H. (2005) Bacterial Vaginosis in Pregnancy: Diagnosis, Screening and Management. Clinics in Perinatology, 32, 617-627.

[33]   Fahey, J.O. (2008) Clinical Management of Intra-Amniotic Infection and Chorioamnionitis: A Review of the Literature. Journal of Midwifery & Women’s Health, 53, 227-235.

[34]   Romero, R., Espinoza, J., Goncalvez, L.F., Kusanovic, J.P., Friel, L.A. and Nien, J.K. (2006) Inflammation in Preterm and Term Labour and Delivery. Seminars in Fetal and Neonatal Medicine, 11, 317-326.

[35]   Uno, K., Kato, K., Atsumi, T., Suzuki, T., Yoshitake, J., Morita, H., et al. (2007) Toll-Like Receptor (TLR) 2 Induced through TLR4 Signaling Initiated by Helicobacter Pylori Cooperatively Amplifies iNOS Induction in Gastric Epithelial Cells. American Journal of Physiology-Gastrointestinal and Liver Physiology, 293, G1004-G1012.

[36]   Weiss, D.S., Raupach, B., Takeda, K., Akira, S. and Zychlinsky, A. (2004) Toll-Like Receptors Are Temporally Involved in Host Defense. Journal of Immunology, 172, 4463-4469.

[37]   Fan, J., Frey, R.S. and Malik, A.B. (2003) TLR4 Signaling Induces TLR2 Expression in Endothelial Cells via Neutrophil NADPH Oxidase. Journal of Clinical Investigation, 112, 1234-1243.

[38]   Lorenz, E. (2006) TLR2 and TLR4 Expression during Bacterial Infections. Current Pharmaceutical Design, 12, 4185-4193.